🚀
Enjoy a 7-Day Free Trial Thru Apr 30, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
ARCA biopharma Inc (NAS:ABIO)
News
ARCA biopharma Inc
NAS
:ABIO (USA) Â
$ 3.45
+0.05 (+1.47%)
10:08 PM EST
P/E:
At Loss
P/B:
1.35
Market Cap:
$ 50.03M
Enterprise V:
$ 12.80M
Volume:
294.62K
Avg Vol (2M):
2.16M
Warning! GuruFocus detected 1 Medium warning sign with ABIO.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
294.62K
Market Cap $:
50.03M
PE Ratio:
At Loss
Avg Vol (2M):
2.16M
Enterprise Value $:
12.80M
PB Ratio:
1.35
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
ARCA biopharma Inc (NAS:ABIO) Stock News, Headlines & Updates
ARCA biopharma Inc Stock News from GuruFocus
Total 70
1
2
Apr 10, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
PRNewswire
•
2:00pm
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO
PRNewswire
•
8:00pm
Apr 05, 2024
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
Business Wire
•
1:00pm
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
PRNewswire
•
1:00pm
Apr 04, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO
PRNewswire
•
10:00am
Apr 03, 2024
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka
PRNewswire
•
2:00pm
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders
Business Wire
•
9:00am
Oct 18, 2023
ARCA biopharma Announces Third Quarter 2023 Financial Results
Marketwired
•
4:00pm
Jul 21, 2023
ARCA biopharma Announces Second Quarter 2023 Financial Results
GlobeNewswire
•
5:00pm
ARCA biopharma Announces Second Quarter 2023 Financial Results
Marketwired
•
4:00pm
Feb 24, 2023
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
sperokesalga
•
4:00pm
Dec 19, 2022
James Flynn Joins ARCA biopharma Board of Directors
Value_Insider
•
4:00pm
Oct 28, 2022
ARCA biopharma Announces Third Quarter 2022 Financial Results
Value_Insider
•
4:00pm
Aug 02, 2022
ARCA biopharma Announces Second Quarter 2022 Financial Results
PurpleRose
•
4:00pm
Jul 11, 2022
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
PurpleRose
•
3:33pm
Jul 01, 2022
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
GuruFocusNews
•
3:32pm
Jun 21, 2022
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
GuruFocusNews
•
3:29pm
Mar 14, 2022
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
GuruFocusNews
•
4:00pm
Dec 02, 2021
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
GuruFocusNews
•
8:00am
Nov 02, 2021
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Don Li2
•
4:01pm
Jul 13, 2021
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
Marketwired
•
8:03am
Jul 09, 2021
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th
Marketwired
•
7:00am
May 04, 2021
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
Marketwired
•
8:02pm
Dec 15, 2020
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
Marketwired
•
11:00am
Dec 10, 2020
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
Marketwired
•
7:00pm
Dec 09, 2020
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
GlobeNewswire
•
5:00pm
Nov 23, 2020
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
Marketwired
•
11:01am
Nov 02, 2020
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Marketwired
•
11:01am
Oct 07, 2020
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
Marketwired
•
11:01am
Oct 06, 2020
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
Marketwired
•
7:01pm
Sep 21, 2020
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
Marketwired
•
11:00am
Aug 06, 2020
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
Marketwired
•
7:02pm
Jul 07, 2020
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
Marketwired
•
11:01am
Jun 03, 2020
ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering
Marketwired
•
11:01am
Jun 01, 2020
ARCA Biopharma Announces $9.4 Million Registered Direct Offering
Marketwired
•
11:02am
May 28, 2020
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
Marketwired
•
11:00am
May 07, 2020
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
Marketwired
•
11:04am
ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update
Marketwired
•
7:02pm
Feb 19, 2020
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
Marketwired
•
7:00pm
Nov 07, 2019
ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update
Marketwired
•
7:00pm
Total 70
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news